Cargando…
Knockdown of long non-coding RNA Taurine Up-Regulated 1 inhibited doxorubicin resistance of bladder urothelial carcinoma via Wnt/β-catenin pathway
In genitourinary system, bladder cancer (BC) is the most common and lethal malignant tumor, which most common type is bladder urothelial carcinoma (BUC). Long non-coding RNA (lncRNA) Taurine Up-Regulated 1 (TUG1) gene is high-expressed in several malignant tumors, including BC. In this study, over-e...
Autores principales: | Xie, Dalong, Zhang, Hui, Hu, Xuanhao, Shang, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687637/ https://www.ncbi.nlm.nih.gov/pubmed/29179467 http://dx.doi.org/10.18632/oncotarget.20927 |
Ejemplares similares
-
Non-coding RNA NEAT1/miR-214-3p contribute to doxorubicin resistance of urothelial bladder cancer preliminary through the Wnt/β-catenin pathway
por: Guo, Yan, et al.
Publicado: (2018) -
WNT/β-catenin signaling in urothelial carcinoma of bladder
por: Garg, Minal, et al.
Publicado: (2019) -
Knockdown of long non-coding RNA SNHG5 inhibits malignant cellular phenotypes of glioma via Wnt/CTNNB1 signaling pathway
por: Hu, Xuanhao, et al.
Publicado: (2019) -
Long non-coding RNA CDKN2B antisense RNA 1 gene inhibits Gemcitabine sensitivity in bladder urothelial carcinoma
por: Xie, Dalong, et al.
Publicado: (2018) -
Non-Coding RNA NEAT1/miR-214-3p Contribute to Doxorubicin Resistance of Urothelial Bladder Cancer Preliminary Through the Wnt/β-Catenin pathway [Retraction]
Publicado: (2022)